Abstract:Background and aims Pancreatic adenocarcinoma (PAAD) is highly aggressive and characterized by a poor prognosis. Oxidative stress has great impacts on the occurrence and development of tumors. However, the predictive role of oxidative stress related genes on PAAD patients’ prognosis remains unclear. In this study, we aimed to construct a prognostic model for PAAD based on oxidative stress genes and to evaluate its predictive value. Methods The Cancer Genome Atlas (TCGA) and three Gene Expression Omnibus (GEO) datasets were used to identify differentially expressed oxidative stress genes. Univariate Cox regression, Kaplan-Meier and multivariate Cox regression analysis were used to select genes and to construct a prognosis model. According to the median value of the model’s risk score, patients were divided into high and low risk groups, and gene set enrichment analysis (GSEA), immune infiltration and immunotherapy effect, drug resistance and the expression of immune checkpoint related genes and synthetic driver genes of T cell proliferation were analyzed. Finally, the mRNA and protein levels of four genes in PAAD were verified by the clinical proteomic tumor analysis consortium (CPTAC) database and the immunostaining of patients’ tissue. Results 55 differentially expressed oxidative stress genes were identified, and four genes including MET, FYN, CTTN and CDK1 were selected to construct a prognosis model. GESA indicated that immune related pathways, metabolic pathways and DNA repair pathways were significantly enriched in the high risk group as compared to the low risk group. The frequency of genetic mutations was also significantly higher in high risk groups than that in low risk groups. Moreover, the infiltration level of 23 immune cells as well as the expression of immune checkpoint related and synthetic driver genes of T cell proliferation were significantly altered, with the better immunotherapy effect occurring in low risk group. In patient PAAD tissues, the mRNA and protein levels of these four genes were up-regulated. Conclusion We have successfully constructed a four oxidative stress gene prognostic model that has important predictive value for PAAD patients, and this model might be a promising guidance for prognostic prediction and efficacy monitoring in clinical individualized therapy.

Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma

Prognostic Risk Model and Tumor Immune Environment Modulation of M5c-Related LncRNAs in Pancreatic Ductal Adenocarcinoma

Prognostic Micrornas and Their Potential Molecular Mechanism in Pancreatic Cancer: A Study Based on the Cancer Genome Atlas and Bioinformatics Investigation

MiRNA-Mediated Subpathway Identification and Network Module Analysis to Reveal Prognostic Markers in Human Pancreatic Cancer

Potential Four‑mirna Signature Associated with Tstage and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma Identified by Co‑expression Analysis

Discovering a Four-Gene Prognostic Model Based on Single-Cell Data and Gene Expression Data of Pancreatic Adenocarcinoma

A Panel Of 13-Mirna Signature As A Potential Biomarker For Predicting Survival In Pancreatic Cancer

Bioinformatics Analysis of a Prognostic Mirna Signature and Potential Key Genes in Pancreatic Cancer

Development and Clinical Validation of a Novel 9-Gene Prognostic Model Based on Multi-Omics in Pancreatic Adenocarcinoma.

An immune-related microRNA signature prognostic model for pancreatic carcinoma and association with immune microenvironment

Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network

A Novel Prognostic Model Based on Three Clinic-Related Mirnas for Prostate Cancer.

A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel

Integrating High-Throughput Microrna and Mrna Expression Data to Identify Risk Mrna Signature for Pancreatic Cancer Prognosis

KLK10/LIPH/PARD6B/SLC52A3 Are Promising Molecular Biomarkers for the Prognosis of Pancreatic Cancer Through a Cerna Network

Identification of Prognosis-Related Molecular Subgroups and Construction of a Prognostic Prediction Model Using Immune-Related Genes in Pancreatic Cancer

Identification of biomarkers for the prognosis of pancreatic ductal adenocarcinoma with miRNA microarray data

A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma

Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients

Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model